
FGFR3 Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 Strategies
Keywords: urinary bladder; urinary bladder neoplasms; receptor, fibroblast growth factor, type 3; cystoscopy; cost-benefit analysisCT, computerized tomography; FGFR3, fibroblast growth factor receptor 3; NMIBC, nonmuscle invasive bladder cancer; TUR, transurethral